NCT04167306View on ClinicalTrials.gov

Varenicline and Bupropion for Alcohol Use Disorder

PHASE2CompletedINTERVENTIONAL
Enrollment

388

Participants

Timeline

Start Date

March 4, 2019

Primary Completion Date

December 15, 2022

Study Completion Date

December 15, 2022

Conditions
Alcohol Use DisorderAlcoholismAlcohol Dependence
Interventions
DRUG

Varenicline Tartrate 1 mg b.i.d

Capsules for oral use

DRUG

Bupropion Hydrochloride 150 mg b.i.d

Capsules for oral use

OTHER

Placebo for varenicline

Capsules for oral use

OTHER

Placebo for bupropion

Capsules for oral use

Trial Locations (4)

Unknown

Beroendecentrum Malmö, Malmo

Linköping University Hospital, Linköping

Stockholm Centre for Dependency Disorders,, Stockholm

Beroendekliniken, Sahlgrenska University Hospital, Västra Götalandsregionen, Gothenburg

All Listed Sponsors
lead

Vastra Gotaland Region

OTHER_GOV

NCT04167306 - Varenicline and Bupropion for Alcohol Use Disorder | Biotech Hunter | Biotech Hunter